Zobrazeno 1 - 10
of 685
pro vyhledávání: '"Masaaki NAKAYAMA"'
Autor:
Haruki Mae, Takuya Fujimaru, Koutarou Shimoyama, Nozomi Kadota, Kasumi Konishi, Yugo Itou, Masahiko Nagahama, Fumika Taki, Masaaki Nakayama
Publikováno v:
Renal Replacement Therapy, Vol 10, Iss 1, Pp 1-8 (2024)
Abstract Background Angiotensin-converting enzyme inhibitors (ACE-I) and angiotensin receptor blockers (ARB) exert a renoprotective effect on patients with chronic kidney disease (CKD). Despite their benefit, one of their side effects is hyperkalemia
Externí odkaz:
https://doaj.org/article/85d1b89ab36a44a4ae1d31608c3b46cf
Autor:
Yoko Tanemoto, Ui Yamada, Masaaki Nakayama, Takeaki Takeuchi, Fumiaki Tanemoto, Yugo Ito, Daiki Kobayashi, Daisuke Ohta, Masahiro Hashizume
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Fatigue in hemodialysis recipients interferes with daily activities and renal rehabilitation, and its underlying causes and treatment remain unclear. Psychological factors, like illness perceptions and alexithymia, cause fatigue in other dis
Externí odkaz:
https://doaj.org/article/8c0f1d2951d349d3a766ae040d8232dd
Autor:
Satoru Kuriyama, Masaaki Nakayama
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Externí odkaz:
https://doaj.org/article/f5b033d9e83241f88594bed4051b2604
Autor:
Shinobu Moriya, Shun Nishizawa, Yayoi Tsuchihashi, Yoshihiro Inoue, Kimio Watanabe, Yugo Ito, Hassu Kin, Masaaki Nakayama
Publikováno v:
Renal Replacement Therapy, Vol 8, Iss 1, Pp 1-9 (2022)
Abstract Background In the Japanese guidelines on combination peritoneal dialysis (PD) and hemodialysis (HD) therapy, patients with serum beta 2 microglobulin (β2MG) levels less than 30 mg/L are recommended. And PD patients with β2MG more than 30 m
Externí odkaz:
https://doaj.org/article/8ed9b87406344594b6d5ffe6d5ec0e11
Publikováno v:
Antioxidants, Vol 13, Iss 1, p 90 (2024)
Chronic kidney disease (CKD), which is globally on the rise, has become an urgent challenge from the perspective of public health, given its risk factors such as end-stage renal failure, cardiovascular diseases, and infections. The pathophysiology of
Externí odkaz:
https://doaj.org/article/502ed94b0df34defb3023daec96d7d4c
Autor:
Susumu Uemura, Yoshitaka Kegasa, Keigo Tada, Taichi Tsukahara, Shigeru Kabayama, Tae Yamamoto, Mariko Miyazaki, Joji Takada, Masaaki Nakayama
Publikováno v:
Renal Replacement Therapy, Vol 8, Iss 1, Pp 1-9 (2022)
Abstract Background Reportedly, dialysis solutions containing molecular hydrogen (H2) might ameliorate patient-reported fatigue in hemodialysis (HD) patients. However, it is unknown whether its impact might differ with different H2 levels. Method Thi
Externí odkaz:
https://doaj.org/article/7b97d83863fa4ff0af34bfbd61c8ba5c
Autor:
Yuki Shinoda-Ito, Kazuhiro Omori, Takashi Ito, Masaaki Nakayama, Atsushi Ikeda, Masahiro Ito, Toshiaki Ohara, Shogo Takashiba
Publikováno v:
Antibiotics, Vol 12, Iss 11, p 1562 (2023)
Dental caries are an oral infectious disease that can affect human health both orally and systemically. It remains an urgent issue to establish a novel antibacterial method to prevent oral infection for a healthy life expectancy. The aim of this stud
Externí odkaz:
https://doaj.org/article/cac874b8c2b34d7293e799e0f83a2b9f
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract The ASTRIO study was a randomised, multicentre, 24-week study that compared the effects of ferric citrate hydrate (FC) and non-iron-based phosphate binders (control) on anaemia management in haemodialysis (HD) patients receiving erythropoies
Externí odkaz:
https://doaj.org/article/7705fdeb260f4bdd8e47266b578929ca
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-12 (2021)
Abstract Background Fibroblast growth factor-23 (FGF23) and α-klotho are associated with anemia in patients with chronic kidney disease. In this post hoc analysis of the ASTRIO study (UMIN000019176), we investigated the relationship between FGF23 an
Externí odkaz:
https://doaj.org/article/75f8f795c9ba4dac989e29a7b7c58b1c
Autor:
Yoshihiro Tsujimoto, Daisuke Kuratsune, Shigeru Kabayama, Mariko Miyazaki, Yasuyoshi Watanabe, Yoshiki Nishizawa, Masaaki Nakayama
Publikováno v:
Renal Replacement Therapy, Vol 7, Iss 1, Pp 1-9 (2021)
Abstract Background Enhanced oxidative stress is involved with fatigue in hemodialysis (HD) patients. Molecular hydrogen (H2) could improve the redox status. Thus, the study examines whether HD solution rendered by electrolyzed water containing H2 (E
Externí odkaz:
https://doaj.org/article/24bc51ed64e74c9e9747226147198ec7